Drug Trial Radar · NCT07189208
Evaluation of Antimicrobial Prophylaxis to Prevent Syphilis in Pregnancy in Patients at Risk in Rio de Janeiro, Brazil
Last checked: Nov 20, 2026Latest source record: Jun 1, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
500
Planned (sponsor's estimate)
Start
Sep 24, 2025
Primary completion
Dec 1, 2029
Study completion Jul 31, 2030
Sponsor
- Lead sponsor
- University of California, Los AngelesAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- National Institute of Allergy and Infectious Diseases (NIAID)
- First posted
- Sep 23, 2025
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Prevention
- FDA-regulated drug
- No
- Who can join
- Female only, from 18 years, up to 45 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The goal of this clinical trial is to learn if benzathine penicillin works to prevent maternal syphilis. It will also learn about the safety of benzathine penicillin. The main questions it aims to answer are: * Does benzathine penicillin lower the rate of syphilis in pregnancy? * What medical problems do participants have when taking benzathine penicillin? Researchers will compare benzathine penicillin to routine care to see if benzathine penicillin works to prevent syphilis. Participants will: * Take benzathine penicillin or receive routine care during the third trimester of pregnancy * Visit the clinic once a month for injections and tests * Report any reactions to benzathine penicillin to the study team
Conditions
- Congenital Syphilis
Interventions
Benzathine penicillin 2.4 million unitsDrug
IM injection of BPG
Counseling and intensified testing.Behavioral
Brazilian Ministry of Health guidelines for the prevention and diagnosis of maternal syphilis consist of counseling about STI prevention and syphilis testing at the first pre-natal consultation, at a subsequent consultation during or after 28 weeks of pregnancy, at delivery, and in case of abortion or stillbirth. In this study, intensified testing refers to treponemal and non-treponemal tests once every four weeks beginning as of the 28th week of pregnancy.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of participants with absence of maternal syphilis infectionTime frame: Labor and delivery
Locations
4 sites in 1 country. Site status is shown where the registry gives one.
Centro de Referencia e Atenção Especializada a Saúde da Mulher (CRAESM)
Duque de Caxias, Rio de Janeiro, Brazil · Not yet recruiting
Policlínica Hospital Municipal Duque de Caxias
Duque de Caxias, Rio de Janeiro, Brazil · Recruiting
Unidade Básica de Saúde José de Freitas
Duque de Caxias, Rio de Janeiro, Brazil · Not yet recruiting
Hospital Federal dos Servidores do Estado
Rio de Janeiro, Rio de Janeiro, Brazil · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.